GB0104752D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB0104752D0
GB0104752D0 GBGB0104752.1A GB0104752A GB0104752D0 GB 0104752 D0 GB0104752 D0 GB 0104752D0 GB 0104752 A GB0104752 A GB 0104752A GB 0104752 D0 GB0104752 D0 GB 0104752D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0104752.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GBGB0104752.1A priority Critical patent/GB0104752D0/en
Publication of GB0104752D0 publication Critical patent/GB0104752D0/en
Priority to PCT/SE2002/000327 priority patent/WO2002067904A1/en
Priority to NZ527080A priority patent/NZ527080A/en
Priority to JP2002567272A priority patent/JP2004527489A/ja
Priority to KR10-2003-7011174A priority patent/KR20040011469A/ko
Priority to CA002435815A priority patent/CA2435815A1/en
Priority to BR0206960-1A priority patent/BR0206960A/pt
Priority to US10/468,246 priority patent/US20040138231A1/en
Priority to MXPA03006746A priority patent/MXPA03006746A/es
Priority to EP02700946A priority patent/EP1365746A1/en
Priority to IL15683002A priority patent/IL156830A0/xx
Priority to CNA028056256A priority patent/CN1533268A/zh
Priority to ZA200305386A priority patent/ZA200305386B/en
Priority to NO20033782A priority patent/NO20033782D0/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GBGB0104752.1A 2001-02-27 2001-02-27 Pharmaceutical compositions Ceased GB0104752D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0104752.1A GB0104752D0 (en) 2001-02-27 2001-02-27 Pharmaceutical compositions
CNA028056256A CN1533268A (zh) 2001-02-27 2002-02-25 含有邻苯二甲酸羟丙基甲基纤维素聚合物的固体分散体的药物组合物
BR0206960-1A BR0206960A (pt) 2001-02-27 2002-02-25 Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
MXPA03006746A MXPA03006746A (es) 2001-02-27 2002-02-25 Composicion farmaceutica que comprende una dispersion solida de un polimero de ftalato de hidroxipropilmetilcelulosa.
JP2002567272A JP2004527489A (ja) 2001-02-27 2002-02-25 フタル酸ヒドロキシプロピルメチルセルロースポリマーの固体分散物を含む医薬組成物
KR10-2003-7011174A KR20040011469A (ko) 2001-02-27 2002-02-25 히드록시프로필메틸셀룰로스 프탈레이트 중합체의 고체분산을 포함하는 약학 조성물
CA002435815A CA2435815A1 (en) 2001-02-27 2002-02-25 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
PCT/SE2002/000327 WO2002067904A1 (en) 2001-02-27 2002-02-25 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
US10/468,246 US20040138231A1 (en) 2001-02-27 2002-02-25 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropyl-methylcellulose phthalate polymer
NZ527080A NZ527080A (en) 2001-02-27 2002-02-25 Oral pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
EP02700946A EP1365746A1 (en) 2001-02-27 2002-02-25 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
IL15683002A IL156830A0 (en) 2001-02-27 2002-02-25 Pharmaceutical compositions which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
ZA200305386A ZA200305386B (en) 2001-02-27 2003-07-11 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer.
NO20033782A NO20033782D0 (no) 2001-02-27 2003-08-26 Farmasöytisk blanding som omfatter en fast dispersjon av hydroksypropylmetylcelluloseftalatpolymer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0104752.1A GB0104752D0 (en) 2001-02-27 2001-02-27 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB0104752D0 true GB0104752D0 (en) 2001-04-18

Family

ID=9909545

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0104752.1A Ceased GB0104752D0 (en) 2001-02-27 2001-02-27 Pharmaceutical compositions

Country Status (14)

Country Link
US (1) US20040138231A1 (cg-RX-API-DMAC7.html)
EP (1) EP1365746A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004527489A (cg-RX-API-DMAC7.html)
KR (1) KR20040011469A (cg-RX-API-DMAC7.html)
CN (1) CN1533268A (cg-RX-API-DMAC7.html)
BR (1) BR0206960A (cg-RX-API-DMAC7.html)
CA (1) CA2435815A1 (cg-RX-API-DMAC7.html)
GB (1) GB0104752D0 (cg-RX-API-DMAC7.html)
IL (1) IL156830A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03006746A (cg-RX-API-DMAC7.html)
NO (1) NO20033782D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ527080A (cg-RX-API-DMAC7.html)
WO (1) WO2002067904A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200305386B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2004105728A2 (en) * 2003-05-27 2004-12-09 Ranbaxy Laboratories Limited Solid dispersions of cefpodoxime proxetil and processes for their preparation
KR100531612B1 (ko) * 2003-08-12 2005-11-28 경동제약 주식회사 지속성 탐스로신 정제의 제조방법 및 그에 따른 지속성탐스로신 정제
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
CA2720851A1 (en) * 2008-04-15 2009-10-22 Schering Corporation Oral pharmaceutical compositions in a molecular solid dispersion
LT2346495T (lt) * 2008-10-07 2016-10-10 Astrazeneca Uk Limited Farmacinė kompozicija 514
US20170087134A1 (en) * 2010-07-12 2017-03-30 Salix Pharmaceuticals, Ltd Formulations of rifaximin and uses thereof
CN104188893A (zh) * 2014-08-18 2014-12-10 赵明亮 一种盐酸环丙沙星口服固体制剂及其制备工艺
KR20240124428A (ko) 2016-09-30 2024-08-16 샐릭스 파마슈티컬스 인코포레이티드 리팍시민의 고체 분산물 형태
WO2025078941A1 (en) * 2023-10-09 2025-04-17 Intas Pharmaceuticals Ltd. Pharmaceutical composition of pirtobrutinib

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57120518A (en) * 1981-01-19 1982-07-27 Tanabe Seiyaku Co Ltd Preparation of microcapsule
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
TW212139B (cg-RX-API-DMAC7.html) * 1991-04-15 1993-09-01 Yamanouchi Pharma Co Ltd
WO1992018106A1 (fr) * 1991-04-16 1992-10-29 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide
US6312726B1 (en) * 1993-08-20 2001-11-06 Nippon Shinyaku Co., Ltd. Gastric remaining preparation, swollen molding, and production process
IL139406A (en) * 1998-05-02 2004-07-25 Astrazeneca Ab Heterocyclic derivatives inhibiting factor XA, pharmaceutical preparations containing them and their use as a drug in the treatment of diseases or conditions mediated by factor XA in warm-blooded animals
AU782469B2 (en) * 1999-12-23 2005-08-04 Mayne Pharma International Pty Ltd Improved pharmaceutical compositions for poorly soluble drugs

Also Published As

Publication number Publication date
NZ527080A (en) 2005-02-25
WO2002067904A1 (en) 2002-09-06
ZA200305386B (en) 2004-10-11
BR0206960A (pt) 2004-03-09
CA2435815A1 (en) 2002-09-06
NO20033782L (no) 2003-08-26
KR20040011469A (ko) 2004-02-05
US20040138231A1 (en) 2004-07-15
MXPA03006746A (es) 2003-10-24
IL156830A0 (en) 2004-02-08
NO20033782D0 (no) 2003-08-26
JP2004527489A (ja) 2004-09-09
CN1533268A (zh) 2004-09-29
EP1365746A1 (en) 2003-12-03

Similar Documents

Publication Publication Date Title
GB0111597D0 (en) Pharmaceutical compositions
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
EP1407785A4 (en) MEDICAL COMPOSITIONS
GB2358583B (en) Pharmaceutical compositions
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0009584D0 (en) Pharmaceutical compositions
GB0117057D0 (en) Pharmaceutical composition
AU8576801A (en) Pharmaceutical compositions
GB0129117D0 (en) Pharmaceutical composition
EP1408896A4 (en) PHARMACEUTICAL COMPOSITION
AU1390002A (en) Pharmaceutical compositions
GB0008485D0 (en) Pharmaceutical compositions
GB0104752D0 (en) Pharmaceutical compositions
GB0116107D0 (en) Pharmaceutical composition
GB0009613D0 (en) Pharmaceutical compositions
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (en) Pharmaceutical composition
GB2382302B (en) Pharmaceutical compositions
IL157411A0 (en) Pharmaceutical composition
GB0126732D0 (en) Pharmaceutical compositions
GB0125061D0 (en) Pharmaceutical composition
HU0103049D0 (en) Pharmaceutical composition
GB0101058D0 (en) Pharmaceutical compositions
HU0105050D0 (en) Pharmaceutical compositions
GB0101744D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)